Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
RS BioTherapeutics Inc. See All Filings	D	2024-10-09 13:12:34 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001932193 Filed Document 0001932193-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-10-09 13:12:34 UTC Type of Offering D Industry Other Health Care Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
RS BioTherapeutics, Inc. See All Filings	C/A	2024-05-22 15:35:35 UTC
Financial Interest Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Filing Platform StartEngine Capital, LLC Offering Amount $1,235,000 CIK Number 0001932193 Filed Document 0001665160-24-000900 Accepted Date 2024-05-22 15:35:35 UTC Type of Offering C/A Security Offered Amount 10,000 Security Offered Type Other State MARYLAND
RS BioTherapeutics, Inc. See All Filings	C	2024-04-29 16:59:29 UTC
Financial Interest Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Filing Platform StartEngine Capital, LLC Offering Amount $1,235,000 CIK Number 0001932193 Filed Document 0001665160-24-000649 Accepted Date 2024-04-29 16:59:29 UTC Type of Offering C Security Offered Amount 10,000 Security Offered Type Other State MARYLAND
RS BioTherapeutics Inc. See All Filings	D/A	2023-10-19 11:43:48 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001932193 Filed Document 0001932193-23-000003 Exclusions or Exemptions 506b Accepted Date 2023-10-19 11:43:48 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
RS BioTherapeutics Inc. See All Filings	D	2023-08-10 16:13:34 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001932193 Filed Document 0001932193-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-08-10 16:13:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
RS BioTherapeutics Inc. See All Filings	D	2023-03-22 14:00:32 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001932193 Filed Document 0001932193-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-03-22 14:00:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity